Daniel Lieber is a research scientist and an entrepreneur. He completed his PhD in Systems Biology from Harvard University where he studied mitochondrial metabolism and bacterial genomics. There, he integrated computational and experimental methods to discover the function of uncharacterized proteins and genetic variants in human disease. Daniel completed his undergraduate training at Princeton University, where he graduated magna cum laude in Molecular Biology with certificates in Quantitative and Computational Biology and Finance and authored his thesis on protein motifs at the Lewis-Sigler Institute of Integrative Genomics. Daniel has received many awards including National Merit Scholar and has multiple publications in peer-reviewed journals. He has taken his extensive knowledge and experience to found Genterpret, a company dedicated to connecting patients to researchers to drive personalized medicine.In this interview, Daniel discusses his passion for genetics which began in the shadow of the famed NIH and both the challenges and opportunities the field presents today. He also talks about this time at Blueprint Health and provides advice for other entrepreneurs.